BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20814351)

  • 1. Establishment of high-performance liquid chromatography and enzyme multiplied immunoassay technology methods for determination of free mycophenolic acid and its application in Chinese liver transplant recipients.
    Chen B; Gu Z; Chen H; Zhang W; Fen X; Cai W; Fan Q
    Ther Drug Monit; 2010 Oct; 32(5):653-60. PubMed ID: 20814351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients.
    de Winter BC; van Gelder T; Sombogaard F; Shaw LM; van Hest RM; Mathot RA
    J Pharmacokinet Pharmacodyn; 2009 Dec; 36(6):541-64. PubMed ID: 19904584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics Evaluation of Mycophenolic Acid and Its Glucuronide Metabolite in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium and Tacrolimus.
    Xu LY; Jiao Z; Liu FY; Qiu XY; Ji L; Zhang M
    Ther Drug Monit; 2018 Oct; 40(5):572-580. PubMed ID: 29847459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models for the prediction of mycophenolic acid area under the curve using a limited-sampling strategy and an enzyme multiplied immunoassay technique in Chinese patients undergoing liver transplantation.
    Chen H; Gu Z; Chen B; Mao H; Zhang W; Fan Q
    Clin Ther; 2008 Dec; 30(12):2387-401. PubMed ID: 19167597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant.
    Atcheson BA; Taylor PJ; Mudge DW; Johnson DW; Hawley CM; Campbell SB; Isbel NM; Pillans PI; Tett SE
    Br J Clin Pharmacol; 2005 Mar; 59(3):271-80. PubMed ID: 15752372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients.
    Shipkova M; Armstrong VW; Weber L; Niedmann PD; Wieland E; Haley J; Tönshoff B; Oellerich M;
    Ther Drug Monit; 2002 Jun; 24(3):390-9. PubMed ID: 12021631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.
    Weber LT; Shipkova M; Lamersdorf T; Niedmann PD; Wiesel M; Mandelbaum A; Zimmerhackl LB; Schütz E; Mehls O; Oellerich M; Armstrong VW; Tönshoff B
    J Am Soc Nephrol; 1998 Aug; 9(8):1511-20. PubMed ID: 9697675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
    Blanchet B; Taieb F; Conti F; Abbas H; Seydi I; Harcouet L; Dauphin A; Calmus Y; Tod M
    Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit.
    Shipkova M; Schütz E; Armstrong VW; Niedmann PD; Oellerich M; Wieland E
    Clin Chem; 2000 Mar; 46(3):365-72. PubMed ID: 10702523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytic validation of the enzyme multiplied immunoassay technique for the determination of mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatographic assay.
    Hosotsubo H; Takahara S; Imamura R; Kyakuno M; Tanaka T; Yazawa K; Hanafusa T; Matsumiya K; Nonomura N; Okuyama A; Sugimoto H
    Ther Drug Monit; 2001 Dec; 23(6):669-74. PubMed ID: 11802102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of unbound mycophenolic acid on inosine monophosphate dehydrogenase inhibition in pediatric kidney transplant patients.
    Smits TA; Cox S; Fukuda T; Sherbotie JR; Ward RM; Goebel J; Vinks AA
    Ther Drug Monit; 2014 Dec; 36(6):716-23. PubMed ID: 24739663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of mycophenolate sodium co-administered with tacrolimus in the first year after renal transplantation.
    Sobiak J; Resztak M; Głyda M; Szczepaniak P; Chrzanowska M
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):331-8. PubMed ID: 25663618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.
    Weber LT; Lamersdorf T; Shipkova M; Niedmann PD; Wiesel M; Zimmerhackl LB; Staskewitz A; Schütz E; Mehls O; Oellerich M; Armstrong VW; Tönshoff B
    Ther Drug Monit; 1999 Oct; 21(5):498-506. PubMed ID: 10519445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparison of the Immunochemical Methods, PETINIA and EMIT, With That of HPLC-UV for the Routine Monitoring of Mycophenolic Acid in Heart Transplant Patients.
    Kunicki PK; Pawiński T; Boczek A; Waś J; Bodnar-Broniarczyk M
    Ther Drug Monit; 2015 Jun; 37(3):311-8. PubMed ID: 25380305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy.
    Weber LT; Shipkova M; Armstrong VW; Wagner N; Schütz E; Mehls O; Zimmerhackl LB; Oellerich M; Tönshoff B
    Clin Chem; 2002 Mar; 48(3):517-25. PubMed ID: 11861442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay.
    Shipkova M; Schütz E; Besenthal I; Fraunberger P; Wieland E
    Ther Drug Monit; 2010 Feb; 32(1):79-85. PubMed ID: 20042920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of the EMIT immunoassay for the measurement of unbound mycophenolic acid in plasma.
    Rebollo N; Calvo MV; Martín-Suárez A; Domínguez-Gil A
    Clin Biochem; 2011 Feb; 44(2-3):260-3. PubMed ID: 20923675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an immunoassay (EMIT) for mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatography assay.
    Beal JL; Jones CE; Taylor PJ; Tett SE
    Ther Drug Monit; 1998 Dec; 20(6):685-90. PubMed ID: 9853989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total and free mycophenolic acid and its 7-O-glucuronide metabolite in Chinese adult renal transplant patients: pharmacokinetics and application of limited sampling strategies.
    Jiao Z; Zhong JY; Zhang M; Shi XJ; Yu YQ; Lu WY
    Eur J Clin Pharmacol; 2007 Jan; 63(1):27-37. PubMed ID: 17093994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of limited sampling strategy for the estimation of mycophenolic acid exposure in Chinese adult liver transplant recipients.
    Hao C; Erzheng C; Anwei M; Zhicheng Y; Baiyong S; Xiaxing D; Weixia Z; Chenghong P; Hongwei L
    Liver Transpl; 2007 Dec; 13(12):1684-93. PubMed ID: 18044788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.